FCA
IONS icon

Florence Capital Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Florence Capital Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$101K Hold
2,000
– – 0.1% 31
2017
Q3 		$101K Hold
2,000
– – 0.11% 27
2017
Q2 		$92K Hold
2,000
– – 0.3% 27
2017
Q1 		$80K Hold
2,000
– – 0.27% 30
2016
Q4 		$96K Buy
+2,000
New +$79.1K 0.11% 28

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Florence Capital Advisors's IONS Position: Q4 2017 in Review

Florence Capital Advisors held its Ionis Pharmaceuticals (IONS) position steady in Q4 2017 at 2,000 shares worth $101K. The position accounts for 0.1% of the portfolio, ranked #31.

Florence Capital Advisors first reported a position in IONS in Q4 2016 and has held it in 5 quarters since. 316 funds tracked by Wall St. Rank hold IONS as of Q4 2017.

  • Florence Capital Advisors held 2,000 shares of Ionis Pharmaceuticals worth $101K as of Q4 2017.
  • Florence Capital Advisors left its Ionis Pharmaceuticals share count unchanged in Q4 2017.
  • Ionis Pharmaceuticals made up 0.1% of Florence Capital Advisors's portfolio in Q4 2017, its #31 holding.
  • Florence Capital Advisors first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 5 quarters since.
  • 316 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2017.

Based on Florence Capital Advisors's 13F filing for Q4 2017, filed 12 Feb 2018.